Uncommitted progenitors in cultures of bone marrow-derived mesenchymal stem cells

Genetic Engineering of Mesenchymal Stem Cells

Volumn , Issue , 2006, Pages 127-133

  Minguell, J J ^a   Erices, A ^a   Sierralta, W D ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900092297     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/1-4020-3959-X_7     Document Type: Chapter

References (52)

1. Pereira RF, Halford KW, O'Hara MD, et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad of Sci USA. 1995;92:4857-4861.
2. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol. 1998;176:57-66.
3. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
4. Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol. 1999;81:67-73.
5. Di Girolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol. 1999;107:275-281.
6. Dennis JE, Merriam A, Awadallah A, Yoo JU, Johnstone B, Caplan AI. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res. 1999;14:700-709.
7. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrowdifferentiate in vitro according to a hierarchical model. J Cell Sci. 2000;113:1161-1166.
8. Caplan AI. The mesengenic process. Clin Plast Surg. 1994;21:429-435.
9. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med. 2001;226:507-520.
10. Bordignon C, Carlo-Stella C, Colombo MP, et al. Cell therapy: achievements and perspectives. Haematologica. 1999;84:1110-1149.
11. Bruder SP, Horowitz MC, Mosca JD, Haynesworth SE. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone. 1997;21:225-235.
12. Morrison SJ, Shah NM, Anderson DJ. Regulatory mechanism instem cell biology. Cell. 1997;88:287-298.
13. Asahara TC, Kalka C, Isner JM. Stem cell therapy and gene transfer for regeneration. Gene Ther. 2000;7:451-457.
14. Castro-Malaspina HC, RE Gay, Resnick G, et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood. 1980;56:289-301.
15. Friedenstein AJ, Chailakhyan RK, Latzinik NV, Panasyuk A, Keilis-Borok IV. Stromal cells responsible for transferring the microenvironment of hemopoietic tissues: cloning in vitro and retransplantation in vivo. Transplantation. 1974;17:331-340.
16. Gronthos S, Zannettino AC, Hay SJ, et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci. 2003;116:1827-1835
17. Mihara K, Imai C, Coustan-Smith E, et al. Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br J Haematol. 2003;120:846-849.
18. Grem JL, Hoth DF, Hamilton JM, King SA, Leyland-Jones B. Overviewof current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid. Cancer Treat Rep. 1987;71:1249-1264.
19. Conget PA, Allers C, Minguell JJ. Identification of a discrete population of human bone-marrow derived mesenchymal cells exhibiting properties of uncommitted progenitors. J Hematother Stem Cell Res. 2001;10:749-758.
20. Mets T, Verdonk G. Variations in the stromal cell population of human bone marrow during aging. Mech Ageing Dev. 1981;15:41-49.
21. Colter DC, Class R, Di Girolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA. 2000;97:3213-3218.
22. Pochampally RR, Smith JS, Sekiya I, Colter DC, Prockop DJ. Selection of rapidly self renewing cells from cultures of adult stem cells from bone marrow stroma. In: Grisolia S, Minana MD, Bendala-Tufanisco E, eds. Mesenchymal Stem Cells: Biology and potential clinical uses. Valencia, Spain: Fundacion Valenciana de Estudios Avanzados; 2003:70-84.
23. Minguell JJ, Erices A, Conget PA, et al. Mesenchymal (uncommitted) Stem Cells. In: Grisolia S, Minana MD, Bendala-Tufanisco E, eds. Mesenchymal Stem Cells: Biology and potential clinical uses. Valencia, Spain: Fundacion Valenciana de Estudios Avanzados; 2003:11-36.
24. Benavente C, Sierralta WD, Conget PA, Minguell JJ. Subcellular distribution and mitogenic effect of basic fibroblast growth factor in mesenchymal uncommitted stem cells. Growth Factors. 2003;21(2):87-94.
25. Kim M, Cooper DD, Hayes SF, Spangrude GJ. Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood. 1998;91:4106-4111.
26. Ratajczak MZ, Pletcher CH, Marlicz W, et al. CD34+, kit+, rhodamine123low phenotype identifies a marrow cell population highly enriched for human hematopoietic stem cells. Leukemia. 1998;12:942.
27. Juan G, Darzynkiewicz Z. Cell cycle analysis by flow and laser scanning cytometry. In: JE Celis, ed. Cell Biology: A Laboratory Handbook. Vol 1. San Diego, CA: Academic Press; 1998:261-272.
28. Iwata S, Sato Y, Asada M, et al. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation. Oncogene. 1999;18:165-172.
29. Wislet-Gendebien S, Leprince P, Moonen G, Rogister B. Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells. J Cell Sci. 2003;116:3295-3302.
30. Deschaseaux F, Gindraux F, Saadi R, Obert L, Chalmers D, Herve P. Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med, low phenotype. Br J Haematol. 2003;122:506-517.
31. Iyer VR, Eisen MB, Ross DT, et al. The transcriptional program in the response of human fibroblasts to serum. Science. 1999;283:83-87.
32. Gregory CA, Singh H, Perry AS, Prockop DJ. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem. 2003;278:28067-28078.
33. Prockop DJ, Gregory CA, Spees JL. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci USA. 2003;100:11917-23.
34. Shou J, Ali-Osman F, Multani AS, Pathak S, Fedi P, Srivenugopal KS. Human Dkk-1, a gene encoding a Wnt antagonist, responds toDNAdamage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA. Oncogene. 2002;21:878-889.
35. Boyden LM, Mao J, Belsky J, et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med. May 16, 2002;346(20):1513-1521.
36. Gronthos S, Simmons PJ. The growth factor requirements of STRO-1-positive human bone marrowstromal precursors under serum-deprived conditions in vitro. Blood. 1995;85:929-939.
37. Kuznetzov SA, Friedenstein AJ, Robey PG. Factors required for bone marrow fibroblast colony formation in vitro. Br J Haematol. 1997;97:561-569.
38. Oliver LJ, Rifkin DB, Gabrilove J, Hannocks MJ, Wilson EL. Long-term culture of bone marrow stromal cells in the presence of basic fibroblast growth factor. Growth Factors. 1990;3:231-239
39. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology. 1997;138:4456-4461.
40. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, Takagishi K, Kato Y. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun. 2001;288:413-422.
41. Erices A, Conget P, Rojas C, Minguell JJ. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Exp Cell Res. 2002;280:24-32.
42. Erladsson A, Enarsson M, Forsberg-Nilsson K. Immature neurons from CNS stem cells proliferate in response to platelet-derived growth factor. J Neurosci. 2001;21:3483-3491.
43. Smith J, Ladi E, Mayer-Proschel M, Noble M. Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc Natl Acad Sci. 2000;97:10032-10037.
44. Ferńandez M, Simon V, Herrera G, Cao C, Del Favero H, Minguell JJ. Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients. Bone Marrow Transplant. 1997;20:265-271.
45. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000;2:477-488.
46. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000;109:235-242.
47. Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998;279:1528-1530.
48. Fruehauf S, Seggewiss R. It's moving day: factors affecting peripheral blood stem mobilization and strategies for improvement. Br J Haematol. 2003;122:360-375.
49. Cancedda R, Bianchi G, Derubeis A, Quarto R. Cell therapy for bone disease: a review of current status. Stem Cells. 2003;21:610-619.
50. Sordella R, Jiang W, Chen GC, Curto M, Settleman J. Modulation of Rho GTPase signaling regulates a switch between. Cell. 2003;113:147-158.
51. Erices AA, Allers CI, Conget PA, Rojas CV, Minguell JJ. Human cord blood-derived mesenchymal stem cells home and survive in the marrow of immunodeficient mice after systemic infusion. Cell Transplant. 2003;12(in press)
52. Watt FM, Hogan BL. Out of Eden: stem cells and their niches. Science. 2000;287:1427-1430.